ANTHONY GUSTITUS: Open Payments
NPI 1801420955 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,469 in 32 payments from 10 companies in 2025. Trend: 2023 $335 · 2024 $553 · 2025 $1,469
Food & beverage: $1,469
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $418 |
| Amgen Inc. | 2 | $239 |
| Corcept Therapeutics | 6 | $224 |
| Tandem Diabetes Care, Inc. | 3 | $168 |
| Medtronic, Inc. | 8 | $165 |
| Sequel Med Tech, LLC | 1 | $141 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $52 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, TEPEZZA, Korlym, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, TWIIST, Wegovy, ISTURISA.
Industry payments across FL — which companies pay providers there.
